Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 3546 entries
View as:

Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02991859 Org: User:
Start: 02/09/17 End: 12/20/18 Due: 12/20/19

Optimising the Propranolol Block Model

Phase: N/A Priority: Normal
NCT ID: NCT00549120 Org: User:
Start: 08/15/07 End: 10/26/07 Due: 10/26/08

To Evaluate Safety & Reactogenicity of GSK Bio's Human Rotavirus (HRV) Vaccine in Filipino Infants at Least 6 Weeks of Age at First Vaccination

Phase: N/A Priority: Normal
NCT ID: NCT00353366 Org: User:
Start: 11/16/06 End: 07/17/10 Due: 07/17/11

Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299)

Phase: N/A Priority: Normal
NCT ID: NCT00637195 Org: User:
Start: 03/11/08 End: 06/18/09 Due: 06/18/10

A Cross-sectional Study on COPD Prevalence

Phase: N/A Priority: Normal
NCT ID: NCT03028207 Org: User:
Start: 03/09/17 End: 03/01/19 Due: 03/01/20

A Repeat Dose Study With GSK1018921 to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics in Healthy Volunteers and Patients With Schizophrenia and to Evaluate Its Effect on PK of Midazolam.

Phase: N/A Priority: Normal
NCT ID: NCT00929370 Org: User:
Start: 07/31/08 End: 03/31/09 Due: 03/31/10

An Open-label Single Dose Randomized, Parallel Group Study Followed by Single-blind Repeat Dosing, to Compare the Relative Bioavailability of GSK2212836.

Phase: N/A Priority: Normal
NCT ID: NCT00996268 Org: User:
Start: 10/15/09 End: 01/04/10 Due: 01/04/11

Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Brazil, Taiwan or Thailand

Phase: N/A Priority: Normal
NCT ID: NCT00849381 Org: User:
Start: 04/30/09 End: 12/31/12 Due: 12/31/13

Eltrombopag/Boceprevir and Eltrombopag/Telaprevir Drug-Drug Interaction Study In Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01657552 Org: User:
Start: 08/01/12 End: 10/26/12 Due: 10/26/13

A Study to Evaluate the Safety, Immunogenicity and Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Malaria Vaccine RTS,S/AS02A, When Administered to Children Aged 1 to 4 Years Living in a Malaria-endemic Region of Mozambique.

Phase: N/A Priority: Normal
NCT ID: NCT00197041 Org: User:
Start: 07/31/03 End: 04/30/05 Due: 04/30/06

Study in Healthy Volunteers, to Evaluate the Safety, Efficacy and Dose Responses of SB-751689 (Ronacaleret)

Phase: N/A Priority: Normal
NCT ID: NCT01802892 Org: User:
Start: 11/02/12 End: 04/02/13 Due: 04/02/14

Spacer Comparison In Adult Asthmatics

Phase: N/A Priority: Normal
NCT ID: NCT00369993 Org: User:
Start: 03/31/05 End: 05/31/05 Due: 05/31/06

Immunogenicity and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Split Virion Influenza Vaccine Fluarix Tetra (2015 Season Southern Hemisphere) in Adults 18 Years of Age and Above

Phase: N/A Priority: Normal
NCT ID: NCT02369341 Org: User:
Start: 04/29/15 End: 06/03/15 Due: 06/03/16

A Post-marketing Safety Study of GSK Bio IPV Vaccine (PoliorixTM) in Korean Children

Phase: N/A Priority: Normal
NCT ID: NCT00514033 Org: User:
Start: 07/31/07 End: 07/31/11 Due: 07/31/12

GI-270384 Study In Patients With Mild To Moderate Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT00457171 Org: User:
Start: 12/31/04 End: - Due: -

Repeat Dose GW685698X With Magnesium Stearate, Excipient Bridging Study, In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00522678 Org: User:
Start: 02/15/07 End: 04/25/07 Due: 04/25/08

A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise

Phase: N/A Priority: Normal
NCT ID: NCT00118690 Org: User:
Start: 12/31/03 End: 12/31/05 Due: 12/31/06

A Study in Korean Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab

Phase: N/A Priority: Normal
NCT ID: NCT01457950 Org: User:
Start: 11/30/11 End: 06/30/13 Due: 06/30/14

Safety and Reactogenicity of GSK Biologicals' Inactivated Poliomyelitis Vaccine (IPV) (Poliorix) in Infants

Phase: N/A Priority: Normal
NCT ID: NCT00937404 Org: User:
Start: 08/04/09 End: 11/13/09 Due: 11/13/10

Study to Assess the Immunogenicity and Safety of GSK's Investigational Vaccine (GSK3277511A) When Given to Healthy Smokers and Ex-smokers After Administration of Shingrix Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT03894969 Org: User:
Start: 04/23/19 End: 08/13/21 Due: 08/13/22

GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults

Phase: N/A Priority: Normal
NCT ID: NCT00089986 Org: User:
Start: 09/01/04 End: 04/15/07 Due: 04/15/08

A Study to Compare to the Pharmacokinetic Profile of Two Paracetamol Formulations

Phase: N/A Priority: Normal
NCT ID: NCT01476189 Org: User:
Start: 11/30/09 End: 12/31/09 Due: 12/31/10

A Study Of GSK189254 And Duloxetine In The Electrical Hyperalgesia Model Of Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00387413 Org: User:
Start: 10/02/06 End: 05/31/07 Due: 05/31/08

Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease. DISKUS® Inhaler is a Trademark of the GSK Group of Companies.

Phase: N/A Priority: Normal
NCT ID: NCT00355342 Org: User:
Start: 04/28/04 End: 09/06/07 Due: 09/06/08

Evaluate the Immunogenicity & Safety of GSK Biologicals' HPV Vaccine in Female Subjects Aged 10-14 Years

Phase: N/A Priority: Normal
NCT ID: NCT00290277 Org: User:
Start: 11/30/05 End: 08/31/06 Due: 08/31/07